Historical record - last NADAC effective date: 9/20/2023
Product Information
FEMYNOR 28 TABLET is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $0.1278 per EA under NDC 69238155106. Its NADAC has been published 342 times since Mar 15, 2017.
FDA first approved this application on Oct 27, 2015.
The High Outlier badge above means this manufacturer's average price in the norgestimate and ethinyl estradiol market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Manufacturer
Amneal Pharmaceuticals NY LLCNDC
69238155106
Classification
Generic
Dosage Form
KIT
Effective Date
9/20/2023
Approval Type
Generic (ANDA)
FDA Application
ANDA203865FDA Approved
10/27/2015
On Market Since
6/15/2016
Price Statistics
The NADAC for FEMYNOR 28 TABLET has been published 342 times since Mar 15, 2017, and over the history we have for it it has declined 57.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1278 per EA |
|---|---|
| All-time high | $0.3516 (Jul 12, 2017) |
| All-time low | $0.1278 (Sep 20, 2023) |
| Median price | $0.2259 |
| Average price | $0.2230 |
| Largest weekly change | +20.3% (Jun 21, 2017) |
| Weeks tracked | 342 |
| Tracking since | Mar 15, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-4.4%
5Y
-37.8%
All
-57.6%
Last surveyed Sep 27, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 15% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FEMYNOR 28 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FEMYNOR 28 TABLET, manufactured by Amneal Pharmaceuticals NY LLC, is $0.1278 per EA (NDC 69238155106), effective Sep 27, 2023.
How has the price of FEMYNOR 28 TABLET changed over time?
Over the history we have for it, the NADAC for FEMYNOR 28 TABLET has declined 57.6%. It has been tracked across 342 weekly CMS publications since Mar 15, 2017.
What are the highest and lowest recorded NADAC prices for FEMYNOR 28 TABLET?
Since Mar 15, 2017, the NADAC for FEMYNOR 28 TABLET has ranged from a low of $0.1278 (Sep 20, 2023) to a high of $0.3516 (Jul 12, 2017), with a median of $0.2259 per EA.
Are there cheaper alternatives to FEMYNOR 28 TABLET?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TRI-LO-ESTARYLLA TABLET, is $0.1083 per EA — about 15% below FEMYNOR 28 TABLET.
Who manufactures FEMYNOR 28 TABLET?
FEMYNOR 28 TABLET (NDC 69238155106) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.